Development and Preclinical Assessment of Antisense Oligonucleotides Targeting Calpain-2, a Critical Effector of Axonal Degeneration

被引：0

|

作者：

Cohen, Joshua ^{[1
]}

Klee, Justin ^{[1
]}

Mizerak, Evan ^{[1
]}

Timmons, Jamie

Canales, Tania Martianez ^{[2
]}

Dekkers, Sebastian ^{[2
]}

van Veen, Femke ^{[2
]}

Eland, Mees ^{[2
]}

Hembury, Mathew ^{[2
]}

Redis, Roxana S. ^{[2
]}

Torroba, Maria Blanca ^{[2
]}

de Wit, Raymond ^{[2
]}

de Munnik, Sabrina ^{[2
]}

机构：

[1] Amylyx Pharmaceut, Cambridge, MA USA

[2] Charles River Labs, Leiden, Netherlands

来源：

MUSCLE & NERVE | 2022年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

11

引用

收藏

页码：S7 / S7

页数：1

相关论文

共 3 条

[1] Update on AMX0114: An Antisense Oligonucleotide Targeting Calpain-2, a Critical Effector of Axonal Degeneration
Cohen, Joshua
Klee, Justin
Mizerak, Evan
Timmons, Jamie
Canales, Tania Martianez
Dekkers, Sebastian
Fan, Tian Shu
van Veen, Femke
Eland, Mees
Hembury, Mathew
Torroba, Maria Blanca
de Wit, Raymond
de Munnik, Sabrina
Redis, Roxana
MUSCLE & NERVE, 2023, 68 : S9 - S10
[2] Preclinical toxicological assessment of amido-bridged nucleic acid-modified antisense oligonucleotides targeting synaptotagmin XIII for intra-abdominal treatment of peritoneal metastasis of gastric cancer
Kanda, Mitsuro
Takano, Nao
Miyauchi, Hiroshi
Ueda, Kohei
Mizuno, Masaaki
Kasahara, Yuuya
Kodera, Yasuhiro
Obika, Satoshi
GASTRIC CANCER, 2024, 27 (06) : 1229 - 1241
[3] Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part 2. Antisense Oligonucleotides
Engelhardt, Jeffery A.
Fant, Pierluigi
Guionaud, Silvia
Henry, Scott P.
Leach, Michael W.
Louden, Calvert
Scicchitano, Marshall S.
Weaver, James L.
Zabka, Tanja S.
Frazier, Kendall S.
TOXICOLOGIC PATHOLOGY, 2015, 43 (07) : 935 - 944